Full name
LINDEN SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
72.11.Z - Research and experimental development on biotechnology
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | 0,1 | 0,6 | 514,8 |
EBITDA | 0,1 | 0,7 | 361,5 | |
Short time liabilities | 0,1 | 0,2 | 94,4 | |
Income tax | 0 | -∞ | ||
Equity capital | -0 | 0,1 | 0,6 | 890,4 |
Operating profit (EBIT) | 0,1 | 0,6 | 474,1 | |
Assets | 0,3 | 0,4 | 1 | 154,1 |
Net profit (loss) | -0 | 0,1 | 0,6 | 554,2 |
Cash | 0,1 | 0,4 | 516,8 | |
Net income from sale | 1,8 | 2,9 | 64,3 | |
Liabilities and provisions for liabilities | 0,4 | 0,3 | 0,4 | 22,6 |
Working assets | 0,2 | 0,3 | 0,9 | 166,2 |
Depreciation | 0 | 0,1 | 40 | |
Basic operational activity income | 1,1 | 194,8 | ||
% | % | % | p.p. | |
Profitability of capital | 136,1 | 89,9 | -46,2 | |
Equity capital to total assets | -6,6 | 15,1 | 59 | 43,9 |
Gross profit margin | -2,6 | 5,6 | 20,9 | 15,3 |
EBITDA Margin | 8,3 | 23,4 | 15,1 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | 21 | 3 | |
Current financial liquidity indicator | 3.3351175785064697 | 4.865942478179932 | 1,6 | |
Net dept to EBITDA | 1.263644814491272 | -0.2051616758108139 | -1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane